SCHEMBL13776953

SCHEMBL13776953

C#Cc1cncc(C(C)(C)C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL179308 0.79 CYP11B1 (0.36) —
SCHEMBL824020 0.77 HSD17B10 (0.32) —
SCHEMBL21121975 0.77 HDAC8 (0.33) —
SCHEMBL15871771 0.71 — —
SCHEMBL9004154 0.71 CYP3A4 (0.33) —
SCHEMBL5958520 0.69 KDM4E (0.32) —
SCHEMBL20469354 0.68 HDAC8 (0.31) —
SCHEMBL24132679 0.67 — —
SCHEMBL21718497 0.67 — —
SCHEMBL22259380 0.67 IDH1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778877-B2 HCV protease inhibitors and uses thereof CELGENE AVILOMICS RESEARCH, INC. (US) 2014-07-15 — — US disclosed
US-20090176858-A1 HCV PROTEASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2009-07-09 — — US disclosed
Send feedback